HEADER TRANSFERASE 25-JUL-02 1M8K TITLE CRYSTAL STRUCTURE OF METHANOBACTERIUM THERMOAUTOTROPHICUM NICOTINAMIDE TITLE 2 MONONUCLEOTIDE ADENYLYLTRANSFERASE MUTANT H19A COMPLEXED WITH NAD COMPND MOL_ID: 1; COMPND 2 MOLECULE: NICOTINAMIDE-NUCLEOTIDE ADENYLYLTRANSFERASE; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: NAD(+) PYROPHOSPHORYLASE, NAD(+) DIPHOSPHORYLASE, NMN COMPND 5 ADENYLYLTRANSFERASE; COMPND 6 EC: 2.7.7.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: METHANOTHERMOBACTER THERMAUTOTROPHICUS; SOURCE 3 ORGANISM_TAXID: 145262; SOURCE 4 GENE: MTH150; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS NUCLEOTIDYLTRANSFERASE HXGH ACTIVE SITE MOTIF, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR V.SARIDAKIS,E.F.PAI REVDAT 6 14-FEB-24 1M8K 1 REMARK REVDAT 5 27-OCT-21 1M8K 1 REMARK SEQADV REVDAT 4 13-JUL-11 1M8K 1 VERSN REVDAT 3 24-FEB-09 1M8K 1 VERSN REVDAT 2 11-NOV-03 1M8K 1 JRNL REVDAT 1 15-JUL-03 1M8K 0 JRNL AUTH V.SARIDAKIS,E.F.PAI JRNL TITL MUTATIONAL, STRUCTURAL, AND KINETIC STUDIES OF THE JRNL TITL 2 ATP-BINDING SITE OF METHANOBACTERIUM THERMOAUTOTROPHICUM JRNL TITL 3 NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE JRNL REF J.BIOL.CHEM. V. 278 34356 2003 JRNL REFN ISSN 0021-9258 JRNL PMID 12810729 JRNL DOI 10.1074/JBC.M205369200 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.9 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 14.99 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 317851.620 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 91.1 REMARK 3 NUMBER OF REFLECTIONS : 18423 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.233 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1822 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.19 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 82.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2448 REMARK 3 BIN R VALUE (WORKING SET) : 0.2590 REMARK 3 BIN FREE R VALUE : 0.2880 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 279 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.017 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4053 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 147 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.61000 REMARK 3 B22 (A**2) : -4.61000 REMARK 3 B33 (A**2) : 9.22000 REMARK 3 B12 (A**2) : 10.61000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM SIGMAA (A) : 0.80 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.37 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.43 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.990 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 5.340 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 8.260 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 7.020 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 10.330; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 14.35 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : NAD.PARAM REMARK 3 PARAMETER FILE 5 : CIS_PEPTIDE.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : NAD.TOP REMARK 3 TOPOLOGY FILE 5 : CIS_PEPTIDE.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1M8K COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-JUL-02. REMARK 100 THE DEPOSITION ID IS D_1000016730. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-SEP-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20207 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 15.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 11.00 REMARK 200 R MERGE (I) : 0.14000 REMARK 200 R SYM (I) : 0.19200 REMARK 200 FOR THE DATA SET : 20.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.11 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.39300 REMARK 200 R SYM FOR SHELL (I) : 0.41800 REMARK 200 FOR SHELL : 6.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1EJ2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 69.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.5 M AMMONIUM SULFATE, 100 MM TRIS, REMARK 280 PH 8, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.27533 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 74.55067 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 74.55067 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 37.27533 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE PROTEIN IS MADE UP OF A DIMER OF TRIMERS. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -111.82600 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 20710 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 36450 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -231.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 1 REMARK 465 MET A 2 REMARK 465 LYS A 172 REMARK 465 GLU A 173 REMARK 465 VAL A 174 REMARK 465 SER A 175 REMARK 465 GLU A 176 REMARK 465 LEU A 177 REMARK 465 GLY A 178 REMARK 465 GLY A 179 REMARK 465 ILE A 180 REMARK 465 SER A 181 REMARK 465 VAL B 1 REMARK 465 MET B 2 REMARK 465 LYS B 172 REMARK 465 GLU B 173 REMARK 465 VAL B 174 REMARK 465 SER B 175 REMARK 465 GLU B 176 REMARK 465 LEU B 177 REMARK 465 GLY B 178 REMARK 465 GLY B 179 REMARK 465 ILE B 180 REMARK 465 SER B 181 REMARK 465 VAL C 1 REMARK 465 MET C 2 REMARK 465 LYS C 172 REMARK 465 GLU C 173 REMARK 465 VAL C 174 REMARK 465 SER C 175 REMARK 465 GLU C 176 REMARK 465 LEU C 177 REMARK 465 GLY C 178 REMARK 465 GLY C 179 REMARK 465 ILE C 180 REMARK 465 SER C 181 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 13 75.82 -113.71 REMARK 500 SER A 103 137.28 178.78 REMARK 500 ASP A 142 70.41 42.05 REMARK 500 GLN B 13 77.55 -113.07 REMARK 500 PRO B 14 -168.26 -103.57 REMARK 500 SER B 39 46.97 40.00 REMARK 500 ALA B 52 -46.87 139.73 REMARK 500 PHE B 125 46.88 -150.64 REMARK 500 TYR B 126 132.69 -19.13 REMARK 500 ARG B 127 178.39 -49.84 REMARK 500 ASP B 128 -148.45 -74.18 REMARK 500 ARG B 129 10.77 48.30 REMARK 500 ASP B 141 34.98 -93.20 REMARK 500 ASP B 142 25.50 46.81 REMARK 500 ASP B 144 75.73 -101.12 REMARK 500 GLN C 13 76.77 -100.67 REMARK 500 SER C 39 48.25 39.65 REMARK 500 ASN C 66 30.12 -92.68 REMARK 500 PRO C 69 122.15 -39.37 REMARK 500 ARG C 129 -30.07 -39.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 1760 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1759 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1761 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD B 2005 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD A 2006 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD C 2004 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1M8F RELATED DB: PDB REMARK 900 NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE MUTANT R11A REMARK 900 COMPLEXED WITH NAD REMARK 900 RELATED ID: 1M8G RELATED DB: PDB REMARK 900 NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE MUTANT R11K REMARK 900 COMPLEXED WITH NAD REMARK 900 RELATED ID: 1M8J RELATED DB: PDB REMARK 900 NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE MUTANT R136A REMARK 900 COMPLEXED WITH NAD DBREF 1M8K A 4 181 UNP O26253 NADM_METTH 1 178 DBREF 1M8K B 4 181 UNP O26253 NADM_METTH 1 178 DBREF 1M8K C 4 181 UNP O26253 NADM_METTH 1 178 SEQADV 1M8K VAL A 1 UNP O26253 CLONING ARTIFACT SEQADV 1M8K MET A 2 UNP O26253 CLONING ARTIFACT SEQADV 1M8K THR A 3 UNP O26253 CLONING ARTIFACT SEQADV 1M8K ALA A 19 UNP O26253 HIS 16 ENGINEERED MUTATION SEQADV 1M8K VAL B 1 UNP O26253 CLONING ARTIFACT SEQADV 1M8K MET B 2 UNP O26253 CLONING ARTIFACT SEQADV 1M8K THR B 3 UNP O26253 CLONING ARTIFACT SEQADV 1M8K ALA B 19 UNP O26253 HIS 16 ENGINEERED MUTATION SEQADV 1M8K VAL C 1 UNP O26253 CLONING ARTIFACT SEQADV 1M8K MET C 2 UNP O26253 CLONING ARTIFACT SEQADV 1M8K THR C 3 UNP O26253 CLONING ARTIFACT SEQADV 1M8K ALA C 19 UNP O26253 HIS 16 ENGINEERED MUTATION SEQRES 1 A 181 VAL MET THR MET ARG GLY LEU LEU VAL GLY ARG MET GLN SEQRES 2 A 181 PRO PHE HIS ARG GLY ALA LEU GLN VAL ILE LYS SER ILE SEQRES 3 A 181 LEU GLU GLU VAL ASP GLU LEU ILE ILE CYS ILE GLY SER SEQRES 4 A 181 ALA GLN LEU SER HIS SER ILE ARG ASP PRO PHE THR ALA SEQRES 5 A 181 GLY GLU ARG VAL MET MET LEU THR LYS ALA LEU SER GLU SEQRES 6 A 181 ASN GLY ILE PRO ALA SER ARG TYR TYR ILE ILE PRO VAL SEQRES 7 A 181 GLN ASP ILE GLU CYS ASN ALA LEU TRP VAL GLY HIS ILE SEQRES 8 A 181 LYS MET LEU THR PRO PRO PHE ASP ARG VAL TYR SER GLY SEQRES 9 A 181 ASN PRO LEU VAL GLN ARG LEU PHE SER GLU ASP GLY TYR SEQRES 10 A 181 GLU VAL THR ALA PRO PRO LEU PHE TYR ARG ASP ARG TYR SEQRES 11 A 181 SER GLY THR GLU VAL ARG ARG ARG MET LEU ASP ASP GLY SEQRES 12 A 181 ASP TRP ARG SER LEU LEU PRO GLU SER VAL VAL GLU VAL SEQRES 13 A 181 ILE ASP GLU ILE ASN GLY VAL GLU ARG ILE LYS HIS LEU SEQRES 14 A 181 ALA LYS LYS GLU VAL SER GLU LEU GLY GLY ILE SER SEQRES 1 B 181 VAL MET THR MET ARG GLY LEU LEU VAL GLY ARG MET GLN SEQRES 2 B 181 PRO PHE HIS ARG GLY ALA LEU GLN VAL ILE LYS SER ILE SEQRES 3 B 181 LEU GLU GLU VAL ASP GLU LEU ILE ILE CYS ILE GLY SER SEQRES 4 B 181 ALA GLN LEU SER HIS SER ILE ARG ASP PRO PHE THR ALA SEQRES 5 B 181 GLY GLU ARG VAL MET MET LEU THR LYS ALA LEU SER GLU SEQRES 6 B 181 ASN GLY ILE PRO ALA SER ARG TYR TYR ILE ILE PRO VAL SEQRES 7 B 181 GLN ASP ILE GLU CYS ASN ALA LEU TRP VAL GLY HIS ILE SEQRES 8 B 181 LYS MET LEU THR PRO PRO PHE ASP ARG VAL TYR SER GLY SEQRES 9 B 181 ASN PRO LEU VAL GLN ARG LEU PHE SER GLU ASP GLY TYR SEQRES 10 B 181 GLU VAL THR ALA PRO PRO LEU PHE TYR ARG ASP ARG TYR SEQRES 11 B 181 SER GLY THR GLU VAL ARG ARG ARG MET LEU ASP ASP GLY SEQRES 12 B 181 ASP TRP ARG SER LEU LEU PRO GLU SER VAL VAL GLU VAL SEQRES 13 B 181 ILE ASP GLU ILE ASN GLY VAL GLU ARG ILE LYS HIS LEU SEQRES 14 B 181 ALA LYS LYS GLU VAL SER GLU LEU GLY GLY ILE SER SEQRES 1 C 181 VAL MET THR MET ARG GLY LEU LEU VAL GLY ARG MET GLN SEQRES 2 C 181 PRO PHE HIS ARG GLY ALA LEU GLN VAL ILE LYS SER ILE SEQRES 3 C 181 LEU GLU GLU VAL ASP GLU LEU ILE ILE CYS ILE GLY SER SEQRES 4 C 181 ALA GLN LEU SER HIS SER ILE ARG ASP PRO PHE THR ALA SEQRES 5 C 181 GLY GLU ARG VAL MET MET LEU THR LYS ALA LEU SER GLU SEQRES 6 C 181 ASN GLY ILE PRO ALA SER ARG TYR TYR ILE ILE PRO VAL SEQRES 7 C 181 GLN ASP ILE GLU CYS ASN ALA LEU TRP VAL GLY HIS ILE SEQRES 8 C 181 LYS MET LEU THR PRO PRO PHE ASP ARG VAL TYR SER GLY SEQRES 9 C 181 ASN PRO LEU VAL GLN ARG LEU PHE SER GLU ASP GLY TYR SEQRES 10 C 181 GLU VAL THR ALA PRO PRO LEU PHE TYR ARG ASP ARG TYR SEQRES 11 C 181 SER GLY THR GLU VAL ARG ARG ARG MET LEU ASP ASP GLY SEQRES 12 C 181 ASP TRP ARG SER LEU LEU PRO GLU SER VAL VAL GLU VAL SEQRES 13 C 181 ILE ASP GLU ILE ASN GLY VAL GLU ARG ILE LYS HIS LEU SEQRES 14 C 181 ALA LYS LYS GLU VAL SER GLU LEU GLY GLY ILE SER HET SO4 A1759 5 HET NAD A2006 44 HET SO4 B1761 5 HET NAD B2005 44 HET SO4 C1760 5 HET NAD C2004 44 HETNAM SO4 SULFATE ION HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE FORMUL 4 SO4 3(O4 S 2-) FORMUL 5 NAD 3(C21 H27 N7 O14 P2) HELIX 1 1 HIS A 16 LEU A 27 1 12 HELIX 2 2 THR A 51 ASN A 66 1 16 HELIX 3 3 PRO A 69 SER A 71 5 3 HELIX 4 4 CYS A 83 THR A 95 1 13 HELIX 5 5 ASN A 105 GLU A 114 1 10 HELIX 6 6 ARG A 127 TYR A 130 5 4 HELIX 7 7 SER A 131 ASP A 141 1 11 HELIX 8 8 TRP A 145 LEU A 149 5 5 HELIX 9 9 PRO A 150 ILE A 160 1 11 HELIX 10 10 ASN A 161 LEU A 169 1 9 HELIX 11 11 HIS B 16 GLU B 28 1 13 HELIX 12 12 ALA B 52 ASN B 66 1 15 HELIX 13 13 CYS B 83 ALA B 85 5 3 HELIX 14 14 LEU B 86 LEU B 94 1 9 HELIX 15 15 ASN B 105 ASP B 115 1 11 HELIX 16 16 SER B 131 ASP B 141 1 11 HELIX 17 17 TRP B 145 LEU B 149 5 5 HELIX 18 18 PRO B 150 ILE B 160 1 11 HELIX 19 19 ASN B 161 LYS B 171 1 11 HELIX 20 20 HIS C 16 LEU C 27 1 12 HELIX 21 21 THR C 51 ASN C 66 1 16 HELIX 22 22 PRO C 69 SER C 71 5 3 HELIX 23 23 CYS C 83 LEU C 94 1 12 HELIX 24 24 ASN C 105 ASP C 115 1 11 HELIX 25 25 ARG C 127 TYR C 130 5 4 HELIX 26 26 SER C 131 ASP C 142 1 12 HELIX 27 27 TRP C 145 LEU C 149 5 5 HELIX 28 28 PRO C 150 ILE C 160 1 11 HELIX 29 29 ASN C 161 LYS C 171 1 11 SHEET 1 A 5 TYR A 73 VAL A 78 0 SHEET 2 A 5 GLU A 32 GLY A 38 1 N ILE A 35 O TYR A 74 SHEET 3 A 5 ARG A 5 GLY A 10 1 N LEU A 8 O CYS A 36 SHEET 4 A 5 ARG A 100 TYR A 102 1 O TYR A 102 N LEU A 7 SHEET 5 A 5 GLU A 118 THR A 120 1 O GLU A 118 N VAL A 101 SHEET 1 B 5 TYR B 73 PRO B 77 0 SHEET 2 B 5 GLU B 32 ILE B 37 1 N ILE B 35 O TYR B 74 SHEET 3 B 5 ARG B 5 GLY B 10 1 N LEU B 8 O CYS B 36 SHEET 4 B 5 ARG B 100 TYR B 102 1 O ARG B 100 N LEU B 7 SHEET 5 B 5 GLU B 118 THR B 120 1 O GLU B 118 N VAL B 101 SHEET 1 C 5 TYR C 73 PRO C 77 0 SHEET 2 C 5 GLU C 32 ILE C 37 1 N ILE C 35 O TYR C 74 SHEET 3 C 5 ARG C 5 GLY C 10 1 N GLY C 6 O ILE C 34 SHEET 4 C 5 ARG C 100 TYR C 102 1 O TYR C 102 N LEU C 7 SHEET 5 C 5 GLU C 118 THR C 120 1 O GLU C 118 N VAL C 101 CISPEP 1 GLN A 13 PRO A 14 0 0.02 CISPEP 2 GLN B 13 PRO B 14 0 -0.18 CISPEP 3 GLN C 13 PRO C 14 0 0.02 SITE 1 AC1 6 ARG C 11 SER C 131 GLY C 132 THR C 133 SITE 2 AC1 6 ARG C 136 NAD C2004 SITE 1 AC2 5 ARG A 11 GLY A 132 THR A 133 ARG A 136 SITE 2 AC2 5 NAD A2006 SITE 1 AC3 6 ARG B 11 SER B 131 GLY B 132 THR B 133 SITE 2 AC3 6 ARG B 136 NAD B2005 SITE 1 AC4 15 VAL B 9 ARG B 11 GLY B 38 SER B 39 SITE 2 AC4 15 ASP B 80 ILE B 81 ASN B 84 TRP B 87 SITE 3 AC4 15 ASN B 105 LEU B 107 PRO B 122 LEU B 124 SITE 4 AC4 15 PHE B 125 TYR B 126 SO4 B1761 SITE 1 AC5 17 VAL A 9 GLY A 10 ARG A 11 VAL A 22 SITE 2 AC5 17 GLY A 38 SER A 39 ASP A 80 ILE A 81 SITE 3 AC5 17 ASN A 84 TRP A 87 ASN A 105 LEU A 107 SITE 4 AC5 17 PRO A 122 LEU A 124 PHE A 125 TYR A 126 SITE 5 AC5 17 SO4 A1759 SITE 1 AC6 16 VAL C 9 GLY C 10 ARG C 11 VAL C 22 SITE 2 AC6 16 GLY C 38 SER C 39 ASP C 80 ILE C 81 SITE 3 AC6 16 ASN C 84 TRP C 87 ASN C 105 PRO C 122 SITE 4 AC6 16 LEU C 124 PHE C 125 TYR C 126 SO4 C1760 CRYST1 124.480 124.480 111.826 90.00 90.00 120.00 P 31 2 1 18 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008033 0.004638 0.000000 0.00000 SCALE2 0.000000 0.009276 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008942 0.00000